Analysts are weighing in on clinical-stage biopharmaceutical company Sarepta Therapeutics Inc (NASDAQ:SRPT) and software company PROS Holdings, Inc. (NYSE:PRO).
Analysts are weighing in on the biopharmaceutical companies Zafgen Inc (NASDAQ:ZFGN) and OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), as shares of both companies fell sharply today due …
In a research report issued Friday, Stifel Nicolaus analyst Benjamin Mogil reiterated a Buy rating on shares of Walt Disney Co (NYSE:DIS), with a …
Equity analysts at the Brokerage firms Stifel Nicolaus and Deutsche Bank are weighing in on the technology giant Apple Inc. (NASDAQ:AAPL) and industrial giant General Electric …
Stifel Nicolaus analyst Scott Devitt was out pounding the table on Paypal Holdings Inc (NASDAQ:PYPL) Monday, upgrading shares from a Hold to a Buy rating, with …
In a research report issued today, Stifel Nicolaus analyst James Albertine offered some commentary on Tesla Motors Inc (NASDAQ:TSLA), after the German automaker Audi announced that it will …
Video streaming website Netflix, Inc. (NASDAQ:NFLX) is slated to announce its second quarter 2015 earnings results on Wednesday, July 15, 2015 after market …
Stifel Nicolaus analyst Kevin Cassidy weighed in with a few comments on Ambarella Inc (NASDAQ:AMBA) after hosting an investor meeting with the company’s CEO, …
By Sarah Roden In a 60 Minutes report aired on March 1, an investigative segment alleged that Lumber Liquidators Holdings (NYSE: LL) has …
